Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
2.
J Neurosci Methods ; 120(1): 1-10, 2002 Oct 15.
Article in English | MEDLINE | ID: mdl-12351201

ABSTRACT

A new combined imaging and chemical detection sensor for the measurement of localized L-glutamate release at the insect neuromuscular junction (NMJ) is presented. The sensor is comprised of an L-glutamate-sensitive fluorescent gel, spin-coated onto the tip of an optical imaging fiber. The gel is composed of L-glutamate oxidase (GLOD); a pH-sensitive fluorescent dye, SNAFL; and poly(acrylamide-co-N-acryloxysuccinimide) (PAN). NH(3) is liberated from the interaction of L-glutamate with GLOD, which reversibly reduces the emitted fluorescence signal from SNAFL. This sensor has a spatial resolution of 3-4 micro m, and an L-glutamate detection limit of between 10 and 100 micro M. L-glutamate release and re-uptake from the foregut plexus of Manduca sexta was detected by the sensor in the presence of the L-glutamate re-uptake blocker dihydrokainate, and the post-synaptic L-glutamate receptor antagonist CNQX.


Subject(s)
Biosensing Techniques/methods , Glutamic Acid/metabolism , Manduca/metabolism , Neuromuscular Junction/metabolism , Animals , Biosensing Techniques/instrumentation , Fluorescence , Glutamic Acid/analysis , Manduca/chemistry , Neuromuscular Junction/chemistry
3.
Pol J Pharmacol ; 53(1): 31-8, 2001.
Article in English | MEDLINE | ID: mdl-11785908

ABSTRACT

To explain the role of the Thr5 residue of proctolin (Arg-Tyr-Leu-Pro-Thr) in the myotropic activity of this insect neuropeptide, we synthesized two groups of its analogues: 1) Arg-Tyr-Leu-Pro-X-OH with X = Val (1), D-Val (2), Ile (3), D-Ile (4), Ala (5), D-Ala (6), Asn (7), Gln (8), Ser (9), Pro (10), Phe (11), Asp (12), Glu (13), Arg (14), D-Arg (15), Lys (16) and Gly (17) and 2) Arg-Tyr-Leu-Pro-R', where R' = isobutylamine (18), S-1-methyl-1-phenylmethylamine (19), R-1-methyl-1-phenylmethylamine (20), R-2-amino-1-propanol (21), S-2-amino-1-propanol (22), R-1-amino-2-propanol (23), S-2-amino-1-propanol (24), 3-amino-1-propanol (25). Decapeptide proctolylproctolin (H-Arg-Tyr-Leu-Pro-Thr-Arg-Tyr-Leu-Pro-Thr-OH) (26) was synthesized. Syntheses of these peptides were carried out by solid-phase method. All peptides were bioassayed in vitro on the semi-isolated hearts of Tenebrio molitor using a cardioexcitatory test and on the foregut of locust (Schistocerca gregaria). Peptides 1, 3, 5, 9, 13, 14, 16, 22, and 23 retained about 30-50% of the cardioexcitatory activity in T. molitor. Analogues 1 and 3 preserved about 50% and analogue 8 about 80% of the myotropic activity, whereas compound 4 and 9 showed a very weak contractile activity in S. gregaria.


Subject(s)
Insecta/chemistry , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Myocardial Contraction/drug effects , Neuropeptides , Oligopeptides/chemistry , Oligopeptides/pharmacology , Animals , Dose-Response Relationship, Drug , Grasshoppers/drug effects , Grasshoppers/physiology , Heart/drug effects , Intestines/drug effects , Intestines/physiology , Neurotransmitter Agents/chemistry , Neurotransmitter Agents/pharmacology , Structure-Activity Relationship , Tenebrio/drug effects , Tenebrio/physiology
4.
Acta Pol Pharm ; 57 Suppl: 88-9, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11293277

ABSTRACT

Novel analogs, modified by L- or D- phenylglycine and p-substituted derivatives, of the neuromodulator proctolin (Arg-Tyr-Leu-Pro-Thr) and of the Trypsin Modulating Oostatic Factor from the gray flesh fly Neobellieria bullata (Neb-TMOF-Asn-Pro-Thr-Asn-Leu-His) were synthesized and checked for activity. Proctolin analogs were modified at position 2: Arg-Phg-Leu-Pro-Thr (I), Arg-D-Phg-Leu-Pro-Thr (II), Arg-Phg(p-OH)-Leu-Pro-Thr (III), Arg-D-Phg(p-OH)-Leu-Pro-Thr (IV), Arg-Phg(p-NO2)-Leu-Pro-Thr (V) Arg-D-Phg(p-NO2)-Leu-Pro-Thr (VI), Arg-Phg(p-NH2)-Leu-Pro-Thr (VII), Arg-D-Phg(p-NH2)-Leu-Pro-Thr (VIII), Arg-Phg(p-N,N-di-Me)-Leu-Pro-Thr (IX), Arg-D-Phg(pp-N,N-di-Me)-Leu-Pro-Thr (X) while analogs of Neb-TMOF underwent modifications at position 6: Asn-Pro-Thr-Asn-Leu-Phg(p-NO2) (XI), Asn-Pro-Thr-Asn-Leu-D-Phg(p-NO2) (XII), Asn-Pro-Thr-Asn-Leu-Phg(p-NH2) (XIII), Asn-Pro-Thr-Asn-Leu-D-Phg(p-NH2) (XIV), Asn-Pro-Thr-Asn-Leu-Phg(p-N,N-di-Me) (XV), Asn-Pro-Thr-Asn-Leu-D-Phg(p-N,N-di-Me) (XVI). Earlier studies on proctolin demonstrated that the presence of the -CH2- group between C-alpha and the phenyl ring at position 2 of the peptide chain is important for the myotropic activity. Based on these results, we replaced Tyr at position 2 by different phenylglycine derivatives, lacking the methylene group at the side chain. Myotropic activity of the proctolin analogs was assayed in vitro on the semi-isolated heart of the mealworm Tenebrio molitor and on the foregut of the locust Schistocerca gregaria. All analogs (I-X) were practically inactive. For Neb-TMOF, it was previously demonstrated that the exchange of His-6 by p-substituted Phe-derivatives, especially by Phe(p-NH2), an amino acid containing a basic function, results into analogs which inhibit trypsin biosynthesis in the gray fleshfly. For this reason these new Neb-TMOF analogs with L- or D-phenylglycine p-substituted derivatives at position 6, were developed and tested (in vivo) in the trypsin biosynthesis assay of the gray fleshfly N. bullata. Only analogs XV and XVI slightly inhibited trypsin biosynthesis in the midgut. Because more than 50% of the injected animals died and none of the surviving animals ate much of the liver meal, the lower trypsin level in the gut might be a indirect effect. Other peptides (XI-XIV) had no effect on the level of trypsin biosynthesis in the midgut.


Subject(s)
Neuropeptides , Neurotransmitter Agents/chemical synthesis , Oligopeptides/chemical synthesis , Animals , Insecta , Oligopeptides/pharmacology , Structure-Activity Relationship , Trypsin/pharmacology
5.
Pol J Pharmacol ; 51(1): 79-85, 1999.
Article in English | MEDLINE | ID: mdl-10389148

ABSTRACT

We have extended our studies on the structure-activity relationship in neuropeptide proctolin (Arg-Tyr-Leu-Pro-Thr) by evaluating the effects of a series of proctolin analogues modified in position 2 of the peptide chain, including: [Phe(p-Cl)2]- (1), [D-Phe(p-Cl)2]- (2), [N-Me-Tyr2]- (3), [D-Phe(p-NH2)2]- (4), [D-Phe(p-N,N-di-Me)2]- (5), [N-Me-Tyr(OMe)]- (6), [D-3-Pal2]- (7), [L-Nal2]- (8), [D-Nal2]- (9), [Lys(Nic)2]- (10), [D-Lys(Nic)2]- (11), [D-Phe-(p-NO2)2]- (12). These peptides were evaluated for myotropic activity on the heart of Tenebrio molitor and contractile activity of the foregut of Schistocerca gregaria. Analogues 1-5, 7-9, and 12 retained a weak cardiotropic activity in Tenebrio molitor while peptides 1, 8 and 12 preserved 15-25% of the locust-gut contracting activity of proctolin. Peptides 2, 4 and 7 showed weak inhibitory activity in Schistocerca gregaria foregut, whereas only peptides 4 and 7 reduced the maximum response to applied proctolin by 64% and 49% respectively, at the 10(-6) M concentration.


Subject(s)
Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Myocardial Contraction/drug effects , Neuropeptides , Neurotransmitter Agents/pharmacology , Oligopeptides/pharmacology , Animals , In Vitro Techniques , Insecta , Intestines/drug effects , Oligopeptides/chemistry , Structure-Activity Relationship , Tenebrio
6.
Pol J Pharmacol ; 50(2): 143-50, 1998.
Article in English | MEDLINE | ID: mdl-9798266

ABSTRACT

We have extended our work on structure/activity relationship of neuropeptide proctolin (H-Arg-Tyr-Leu-Pro-Thr-OH) by evaluating the effects of the following proctolin analogues: H-X1-Tyr-Leu-Pro-Thr-OH, where X1 = D-Arg (1), N-Me-Arg (2), Can (3), D-Tyr2, D-Leu3, D-Thr5]-proctolin (12). In analogues 1-9, the N-terminal Arg-residue was replaced by basic amino acid derivatives with peptides containing amino acid residues with an isosteric system on the back side chain relative to Arg (compounds 3, 5 and 6) or homo-Arg (compound 7). Analogues 1-12 were evaluated for myotropic action on in vitro heart preparation of Tenebrio molitor, whereas peptides 2, 5 and 7-12 were tested for contractile action on isolated foregut of Schistocerca gregaria. Peptides 2 and 3 retained full cardiotropic activity in Tenebrio molitor while peptides 5 and 7 preserved 40% and 15%, respectively, locust-gut contracting activity of proctolin. Peptides 11 and 12 showed antagonistic activity in Schistocerca gregaria foregut.


Subject(s)
Grasshoppers/physiology , Heart/drug effects , Neuropeptides , Oligopeptides/pharmacology , Tenebrio/physiology , Animals , Dose-Response Relationship, Drug , In Vitro Techniques , Male , Myocardial Contraction/drug effects , Oligopeptides/chemical synthesis
7.
J Cardiovasc Electrophysiol ; 8(6): 700-21, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9209972

ABSTRACT

A number of clinical cardiac disorders may be associated with a rise of the intracellular Na concentration (Na(i)) in heart muscle. A clear example is digitalis toxicity, in which excessive inhibition of the Na/K pump causes the Na(i) concentration to become raised above the normal level. Especially in digitalis toxicity, but also in many other situations, the rise of Na(i) may be an important (or contributory) cause of increased cardiac arrhythmias. In this review, we consider the mechanisms by which a raised Na(i) may cause cardiac arrhythmias. First, we describe the factors that regulate Na(i), and we demonstrate that the equilibrium level of Na(i) is determined by a balance between Na entry into the cell, and Na extrusion from the cell. A number of mechanisms are responsible for Na entry into the cell, whereas the Na/K pump appears to be the main mechanism for Na extrusion. We then consider the processes by which an increased level of Nai might contribute to cardiac arrhythmias. A rise of Na(i) is well known to result in an increase of intracellular Ca, via the important and influential Na/Ca exchange mechanism in the cell membrane of cardiac muscle cells. A rise of intracellular Ca modulates the activity of a number of sarcolemmal ion channels and affects release of intracellular Ca from the sarcoplasmic reticulum, all of which might be involved in causing arrhythmia. It is possible that the increase in contractile force that results from the rise of intracellular Ca may initiate or exacerbate arrhythmia, since this will increase wall stress and energy demands in the ventricle, and an increase in wall stress may be arrhythmogenic. In addition, the rise of Na(i) is anticipated to modulate directly a number of ion channels and to affect the regulation of intracellular pH, which also may be involved in causing arrhythmia. We also present experiments in this review, carried out on the working rat heart preparation, which suggest that a rise of Na(i) causes an increase of wall stress-induced arrhythmia in this model. In addition, we have investigated the effect on wall stress-induced arrhythmia of maneuvers that might be anticipated to change intracellular Ca, and this has allowed identification of some of the factors involved in causing arrhythmia in the working rat heart.


Subject(s)
Arrhythmias, Cardiac/metabolism , Sodium/metabolism , Action Potentials/physiology , Animals , Arrhythmias, Cardiac/etiology , Arrhythmias, Cardiac/physiopathology , Biological Transport , Calcium/metabolism , Carrier Proteins/metabolism , Gap Junctions/metabolism , Humans , Hydrogen-Ion Concentration , Myocardial Contraction/physiology , Myocardium/metabolism , Sodium-Calcium Exchanger , Sodium-Potassium-Exchanging ATPase/metabolism
8.
J Electron Microsc (Tokyo) ; 46(2): 165-70, 1997.
Article in English | MEDLINE | ID: mdl-9180031

ABSTRACT

Excitation-contraction coupling in cardiac muscle is thought to depend fundamentally on the spatial organization of sarcolemmal dihydropyridine receptors (L-type calcium channels) in relation to ryanodine receptors (calcium-release channels of the sarcoplasmic reticulum). In the present study, we have investigated the distribution of dihydropyridine receptors in the guinea pig myocyte plasma membrane by correlative immunoconfocal microscopy and label-fracture electron microscopy. Label-fracture, a method in freeze-fracture cytochemistry, permits immunogold localization of cell surface proteins in en face membrane views. Taken together, results from confocal microscopy and label-fracture replicas suggest that, in the peripheral plasma membrane, calcium channels are organized predominantly in the form of clusters. Confocal microscopy also suggests a similar organization in the transverse tubules. It is hypothesized that these clusters may lie adjacent to junctional sarcoplasmic reticulum, permitting the close coupling of influx of calcium through plasma membrane calcium channels to trigger release of calcium from the intracellular stores, as part of the mechanism of calcium-induced calcium release.


Subject(s)
Calcium Channels/analysis , Microscopy, Confocal/methods , Microscopy, Immunoelectron/methods , Myocardium/chemistry , Animals , Calcium Channels, L-Type , Cell Membrane/chemistry , Fluorescent Antibody Technique, Indirect , Freeze Fracturing , Guinea Pigs , Myocardium/cytology
9.
J Physiol ; 493 ( Pt 1): 19-37, 1996 May 15.
Article in English | MEDLINE | ID: mdl-8735692

ABSTRACT

1. We used a rapid solution switcher technique to investigate mechanisms that might trigger intracellular Ca2+ release in rabbit ventricular myocytes. The study was carried out at 36 degrees C, intracellular Ca2+ (Ca2+i) was monitored with fura-2, and myocytes were electrically stimulated. 2. In patch-clamped cells, using the switcher to apply 20 microM nifedipine (an L-type Ca2+ current (ICa,L) blocker) 4 s before a depolarization to +10 mV reduced the amplitude of ICa,L to 10.25 +/- 2.25% of control (mean +/- S.E.M., n = 7 cells). 3. In externally stimulated cells, a rapid switch to 20 microM nifedipine 4 s before a stimulus reduced the amplitude of the fura-2 transient to 64.01 +/- 2.09% of control (mean +/- S.E.M., n = 19 cells). Using an in vivo calibration curve for fura-2, this was equivalent to a reduction in the Ca2+ transient to 50% during nifedipine application. Since an identical nifedipine switch reduced ICa,L to 10.25%, it would seem that blocking a large fraction of ICa,L inhibited only half the Ca2+ transient. 4. The Na(+)-Ca2+ exchanger is inhibited by 5 mM nickel. Switching to 20 microM nifedipine +5 mM nickel 4 s before a stimulus abolished the fura-2 transient completely, consistent with the hypothesis that Ca2+ entry via reverse Na(+)-Ca2+ exchange might trigger a fraction of the fura-2 transient that remained during nifedipine. 5. After the Na(+)-K+ pump was inhibited by strophanthidin to increase intracellular Na+ (Na+i), a switch to 20 microM nifedipine became progressively less effective in reducing the fura-2 transient. This suggests that as Na+i rose, other mechanisms (perhaps reverse Na(+)-Ca2+ exchange) appeared able to substitute for ICa,L in triggering the Ca2+ transient. 6. In cells depleted of Nai+ to inhibit the triggering of sarcoplasmic reticulum (SR) Ca2+ release by reverse Na(+)-Ca2+ exchange, a nifedipine switch reduced the fura-2 transient to 10.9 +/- 4.19% (mean +/- S.E.M., n = 7; equivalent to 6.5% of the Ca2+ transient). 7. A switch to Na(+)-free (Li+) solution 100 ms before an electrical stimulus caused an increase in the fura-2 transient of 12.2 +/- 1.5% (mean +/- S.E.M., n = 7; equivalent to a 22% increase in the Ca2+ transient). 8. The results confirm that ICa,L is an important trigger for SR Ca2+ release and the resulting Ca2+ transient. However, since 50% of the Ca2+ transient remained when ICa,L was largely inhibited, it would seem likely that other SR trigger mechanisms might exist in addition. These data are consistent with the idea that Ca2+ entry via reverse Na(+)-Ca2+ exchange during the upstroke of the normal cardiac action potential might trigger a fraction of SR Ca2+ release and the resulting Ca2+ transient.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium/metabolism , Myocardium/metabolism , Animals , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/metabolism , Cell Size/drug effects , Cell Size/physiology , Cells, Cultured , Electrophysiology , Enzyme Inhibitors/pharmacology , Fura-2/metabolism , Male , Nickel/pharmacology , Nifedipine/pharmacology , Rabbits , Ryanodine/pharmacology , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum/metabolism , Sodium/metabolism , Sodium-Calcium Exchanger , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Strophanthidin/pharmacology , Thapsigargin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...